Immuron Limited

Q: What was Immuron Limited’s price range in the past 12 months?

Immuron Limited lowest share price was AU$0.05 and its highest was AU$0.10 in the past 12 months.

Q: What is Immuron Limited’s market cap?

Immuron Limited’s market cap is AU$21.82M.

Q: When is Immuron Limited’s upcoming earnings report date?

Immuron Limited’s upcoming earnings report date is Mar 04, 2026 which is in 120 days.

Q: How were Immuron Limited’s earnings last quarter?

Immuron Limited released its earnings results on Sep 02, 2025. The company reported AU$0 earnings per share for the quarter, the consensus estimate of N/A by AU$0.

Q: Is Immuron Limited overvalued?

According to Wall Street analysts Immuron Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Immuron Limited pay dividends?

Immuron Limited does not currently pay dividends.

Q: What is Immuron Limited’s EPS estimate?

Immuron Limited’s EPS estimate is 0.

Q: How many shares outstanding does Immuron Limited have?

Immuron Limited has 269,353,820 shares outstanding.

Q: What happened to Immuron Limited’s price movement after its last earnings report?

Immuron Limited reported an EPS of AU$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Immuron Limited?

Currently, no hedge funds are holding shares in AU:IMC

Compare

8 Followers

IMC Stock Chart & Stats

AU$0.09

<AU$0.01(3.80%)

At close: Jan 09 4:00 PM EST

AU$0.09

<AU$0.01(3.80%)

Day’s Range― - ―

52-Week RangeAU$0.05 - AU$0.10

Previous CloseN/A

Volume128.40K

Average Volume (3M)283.57K

Market Cap

AU$21.82M

Enterprise ValueAU$8.36M

Total Cash (Recent Filing)AU$5.87M

Total Debt (Recent Filing)AU$117.13K

Price to Earnings (P/E)―

Beta1.46

Next Earnings

Mar 04, 2026

EPS Estimate

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding269,353,820

10 Day Avg. Volume363,262

30 Day Avg. Volume283,571

Financial Highlights & Ratios

PEG Ratio0.11

Price to Book (P/B)1.75

Price to Sales (P/S)1.93

P/FCF Ratio-2.30

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Immuron Limited News

Immuron submitts IND application to FDA for clinical development of IMM-529

Immuron (IMRN) announced that it has submitted an Investigational New Drug, or IND, application to the FDA for...

27d ago

IMRN

Immuron Updates on Clinical Trials and FDA Interactions

The latest announcement is out from Immuron Limited ( ($AU:IMC) ). Immuron Limited has provided an update on...

5d ago

Immuron Limited Announces Cessation of 500,000 Securities

Immuron Limited ( ($AU:IMC) ) just unveiled an announcement. Immuron Limited announced the cessation of 500,000 securities due...

9d ago

Immuron Limited Launches PROIBS® for IBS Relief in Australia

Immuron Limited ( ($AU:IMC) ) has shared an update. Immuron Limited has launched PROIBS®, a new product aimed...

12d ago

Immuron CEO to Present at Emerging Growth Conference

Immuron Limited ( ($AU:IMC) ) has provided an announcement. Immuron Limited announced that its CEO, Steven Lydeamore, will...

13d ago

Immuron CEO to Present at AusBiotech Invest 2025 Conference

Immuron Limited ( ($AU:IMC) ) has issued an update. Immuron Limited announced that its CEO, Steven Lydeamore, will...

15d ago

Immuron Limited Issues New Shares, Ensures Compliance

An update from Immuron Limited ( ($AU:IMC) ) is now available. Immuron Limited has announced the issuance of...

16d ago

Immuron Limited Announces Quotation of New Securities on ASX

An update from Immuron Limited ( ($AU:IMC) ) is now available. Immuron Limited has announced the quotation of...

16d ago

Immuron Limited Reports Strong Q1 FY26 Sales Growth

An announcement from Immuron Limited ( ($AU:IMC) ) is now available. Immuron Limited reported a 34% year-over-year increase...

23d ago

Immuron Limited Announces 2025 Annual General Meeting

Immuron Limited ( ($AU:IMC) ) has shared an update. Immuron Limited has announced its 2025 Annual General Meeting,...

26d ago

Immuron Advances CDI Treatment with FDA Submission for IMM-529

Immuron Limited ( ($AU:IMC) ) has issued an announcement. Immuron Limited has submitted an Investigational New Drug (IND)...

28d ago

Immuron announces projects update

Immuron (IMRN) is pleased to provide shareholders with a brief update on progress with a number of projects....

1M ago

IMRN

Immuron enters partnership with InvestorHub

Immuron (IMRN) advises it has entered into a partnership with InvestorHub, a direct-to-investor engagement software company that provides...

2M ago

IMRN

Immuron says FY25 global sales exceed projection, up 49% over prior year

Immuron (IMRN) is pleased to announce continued sales growth of Travelan, an over-the-counter immune supplement that targets pathogenic...

4M ago

IMRN

IMC FAQ

What was Immuron Limited’s price range in the past 12 months?

Immuron Limited lowest share price was AU$0.05 and its highest was AU$0.10 in the past 12 months.

What is Immuron Limited’s market cap?

Immuron Limited’s market cap is AU$21.82M.

When is Immuron Limited’s upcoming earnings report date?

Immuron Limited’s upcoming earnings report date is Mar 04, 2026 which is in 120 days.

How were Immuron Limited’s earnings last quarter?

Immuron Limited released its earnings results on Sep 02, 2025. The company reported AU$0 earnings per share for the quarter, the consensus estimate of N/A by AU$0.

Is Immuron Limited overvalued?

According to Wall Street analysts Immuron Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Immuron Limited pay dividends?

Immuron Limited does not currently pay dividends.

What is Immuron Limited’s EPS estimate?

Immuron Limited’s EPS estimate is 0.

How many shares outstanding does Immuron Limited have?

Immuron Limited has 269,353,820 shares outstanding.

What happened to Immuron Limited’s price movement after its last earnings report?

Immuron Limited reported an EPS of AU$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Immuron Limited?

Currently, no hedge funds are holding shares in AU:IMC

Immuron Limited Stock Smart Score

Neutral

Blogger Sentiment

Bullish

AU:IMC Sentiment 70%
Sector Average ―

Technicals

Fundamentals

Return on Equity

-49.96%

Trailing 12-Months

Asset Growth

-41.64%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Immuron Limited

Immuron Limited (IMC) is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products. The company operates primarily in the biotechnology sector, specializing in immunotherapy and leveraging its proprietary technology to create products aimed at treating and preventing various diseases, including gastrointestinal disorders and liver diseases. Immuron's core products include its lead candidate, Travelan, which is designed to prevent travelers' diarrhea, and other pipeline products targeting conditions influenced by the immune system.